He is engaged in hands-on research in the field of computational biochemistry. His lab focuses on the design of novel algorithms and machine architectures for high-speed biomolecular simulations and on the use of such simulations to study atomic-level structural changes in proteins, nucleic acids, and other biologically significant molecules. The group’s long-term goal is to significantly advance the process of drug discovery, providing a potentially powerful new tool for combating a wide range of different diseases.